NVS Earnings Date: Feb 3, 2027 (Estimated) — Novartis AG
NYSE · Healthcare · Drug Manufacturers - General
Updated
When is NVS's next earnings date?
Novartis AG (NVS) is expected to report Q4 2026 earnings on Wednesday, February 3, 2027 at 1:00 AM ET (before market open); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of $2.12 on revenue of $14.94B.
How did NVS do in its last earnings report?
In its most recent report on Oct 27, 2026 (Q3 2026), Novartis AG posted EPS of $2.46 versus the $2.25 estimate, a beat of 9.3%. Revenue was $14.52B against a $14.53B estimate. The stock's 1-day post-earnings move was +2.0%.
How much does NVS stock move after earnings?
NVS beat EPS estimates in 6 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 2.0% (up or down) in the day after earnings.
About Novartis AG
Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. Its product portfolio is heavily focused on innovative prescription medicines, especially oncology, immunology, neuroscience, and cardiovascular diseases, supplemented by established older brands and a wide range of specialized therapies. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.
🤖 AI Earnings Analysis
Novartis raised guidance on solid sales and productivity, a positive signal despite clinical-trial setbacks. Q3 EPS beat estimates by $0.22 at $2.46, but revenue grew just 4% to $14.5 billion and missed.
AI-generated summary — powered by BigEarnings.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-27 | Q3 2026 | 2.25 | 2.46 | +9.33% | $14.52B | ✅ Beat | +1.98% | — | — |
| 2026-07-21 | Q2 2026 | 2.16 | 2.41 | +11.57% | $14.41B | ✅ Beat | +2.88% | +4.38% | +3.34% |
| 2026-04-28 | Q1 2026 | 2.07 | 1.99 | -3.86% | $13.11B | ❌ Miss | +0.91% | +0.30% | +4.81% |
| 2026-02-04 | Q4 2025 | 2.00 | 2.03 | +1.50% | $13.34B | ✅ Beat | +2.03% | +5.56% | +7.44% |
| 2025-10-28 | Q3 2025 | 2.29 | 2.25 | -1.75% | $13.91B | ❌ Miss | -4.42% | -4.09% | +0.87% |
| 2025-07-17 | Q2 2025 | 2.38 | 2.42 | — | $14.05B | ✅ Beat | -3.25% | -0.34% | +3.14% |
| 2025-04-29 | Q1 2025 | 2.08 | 2.28 | +9.62% | $13.23B | ✅ Beat | +0.73% | +0.40% | -0.67% |
| 2025-01-31 | Q4 2024 | 1.79 | 1.98 | +10.61% | $13.15B | ✅ Beat | -0.03% | +2.12% | +5.60% |
Showing last 8 quarters.